Paper57118
Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity.
Bech-Hansen NT and 2 others. J Cell Physiol, 1976. Cited by 319 papers, by iCite.
Cite this record
ConductScience Library. Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity. Papers, record 57118. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/57118
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colchicine | Major topic |
| Drug Resistance | Major topic |
| Anesthetics, Local | |
| Cell Line | |
| Cell Membrane Permeability | |
| Gramicidin | |
| Mutation | |
| Octanols | |
| Phenotype | |
| Polyethylene Glycols | |
| Solubility | |
| Steroids | |
| Vinblastine |
Source PubMed
Cited by62
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 319 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40723843 | Predictive and Prognostic Relevance of ABC Transporters for Resistance to Anthracycline Derivatives. | Biomolecules | 2025 | https://conductscience.org/library/papers/40723843 | PubMed |
| 36609245 | The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells. | BMC Cancer | 2023 | https://conductscience.org/library/papers/36609245 | PubMed |
| 31406162 | Danazol mediates collateral sensitivity via STAT3/Myc related pathway in multidrug-resistant cancer cells. | Sci Rep | 2019 | https://conductscience.org/library/papers/31406162 | PubMed |
| 24800945 | Uptake of compounds that selectively kill multidrug-resistant cells: the copper transporter SLC31A1 (CTR1) increases cellular accumulation of the thiosemicarbazone NSC73306. | Mol Pharm | 2014 | https://conductscience.org/library/papers/24800945 | PubMed |
| 24758331 | Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance. | Chem Rev | 2014 | https://conductscience.org/library/papers/24758331 | PubMed |
| 24492893 | Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy? | Drug Metab Dispos | 2014 | https://conductscience.org/library/papers/24492893 | PubMed |
| 24478983 | Small and Innovative Molecules as New Strategy to Revert MDR. | Front Oncol | 2014 | https://conductscience.org/library/papers/24478983 | PubMed |
| 24305879 | MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer. | Cancer Res | 2014 | https://conductscience.org/library/papers/24305879 | PubMed |
| 24177951 | Isolation and characterization of an uncoupler-resistant mutant of Saccharomyces cerevisiae. | Curr Genet | 1984 | https://conductscience.org/library/papers/24177951 | PubMed |
| 22676443 | Transfected MDCK cell line with enhanced expression of CYP3A4 and P-glycoprotein as a model to study their role in drug transport and metabolism. | Mol Pharm | 2012 | https://conductscience.org/library/papers/22676443 | PubMed |
| 22483810 | Collateral sensitivity as a strategy against cancer multidrug resistance. | Drug Resist Updat | 2012 | https://conductscience.org/library/papers/22483810 | PubMed |
| 20629994 | Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties. | J Cell Mol Med | 2011 | https://conductscience.org/library/papers/20629994 | PubMed |
| 19762091 | Is resistance useless? Multidrug resistance and collateral sensitivity. | Trends Pharmacol Sci | 2009 | https://conductscience.org/library/papers/19762091 | PubMed |
| 16862376 | Preface: the concept and consequences of multidrug resistance. | Pflugers Arch | 2007 | https://conductscience.org/library/papers/16862376 | PubMed |
| 11355953 | Effect of P-glycoprotein on flavopiridol sensitivity. | Br J Cancer | 2001 | https://conductscience.org/library/papers/11355953 | PubMed |
| 10704438 | In situ biochemical demonstration that P-glycoprotein is a drug efflux pump with broad specificity. | J Cell Biol | 2000 | https://conductscience.org/library/papers/10704438 | PubMed |
| 8824346 | Evaluation of 2,6-diamino-N-([1-(1-oxotridecyl)-2-piperidinyl]methyl)- hexanamide (NPC 15437), a protein kinase C inhibitor, as a modulator of P-glycoprotein-mediated resistance in vitro. | Invest New Drugs | 1996 | https://conductscience.org/library/papers/8824346 | PubMed |
| 8483936 | Functional replacement of the hemolysin A transport signal by a different primary sequence. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8483936 | PubMed |
| 8369114 | Chemotherapeutic drug resistance in the management of head and neck cancer. | Eur Arch Otorhinolaryngol | 1993 | https://conductscience.org/library/papers/8369114 | PubMed |
| 8347489 | Interaction of multidrug-resistant Chinese hamster ovary cells with amphiphiles. | Br J Cancer | 1993 | https://conductscience.org/library/papers/8347489 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/57118
GET https://conductscience.org/api/papers/v1/57118/cited_by?page=2